Stocks and Investing Stocks and Investing
Thu, August 31, 2023
Wed, August 30, 2023
Tue, August 29, 2023
Mon, August 28, 2023

Luca Issi Reiterated (ALNY) at Buy and Held Target at $270 on, Aug 28th, 2023


Published on 2024-10-28 06:10:09 - WOPRAI
  Print publication without navigation


Luca Issi of RBC Capital, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $270 on, Aug 28th, 2023.

Luca has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Wednesday, August 16th, 2023
  • Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023


These are the ratings of the 5 analyists that currently disagree with Luca


  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, August 7th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, August 4th, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023